Company Overview and News
LOS ANGELES, Oct. 04, 2018 (GLOBE NEWSWIRE) -- B. Riley FBR, Inc., a leading full service investment bank and wholly-owned subsidiary of B. Riley Financial, Inc., announced today that it is set to host its Annual Consumer & Media Conference today, October 4th in New York City.
Cedar Fair Entertainment Company (NYSE: FUN), a leader in regional amusement parks, water parks and immersive entertainment, will hold its quarterly conference call with investors to discuss 2018 third-quarter earnings on Tuesday, October 30, at 10:00 a.m. Eastern Time.
SeaWorld Entertainment, Inc. (SEAS - Free Report) recently announced preliminary revenue and attendance results for third-quarter 2018 that ended on Sep 30, 2018. The company reported initial numbers because of a possible debt-refinancing transaction.
SEAS RDIB RDI FUN
WallStars are distinguished by positive broker target price upsides. SALM, IGT, UFAB, SKIS, G, WYND, LVS, TUP, EVE, and ESCA topped the sector for broker price target upsides 9/5/18.
EVC NOBGF IGT SKIS LB FUN WYND CSS UFAB N21 CATO NOBGY BKS GM LVS TUP SALM
2018-09-06 sec.gov - 2
Document UNITED STATES
Extra Space Storage Inc (EXR - Free Report) recently added a new property to its third-party management platform — ManagementPlus — taking the total number of the company’s properties under management to 500. Further, in a poll conducted by Inside Self Storage, the company has emerged as the best third-party management company for the seventh year in a row, winning the title of 2018 “Best of Business.
MDQZZ VICI MRT EXR BGSF FUN
Bringing in good news for shareholders, Britain-based Royal Bank of Scotland (RBS - Free Report) came up with the first dividend announcement, along with its second-quarter 2018 earnings release, since its bailout by the Government in 2008. The move follows the bank’s aims to get its state stake reduced. Notably, the British government currently has a 62.4% stake in RBS which was taken up by paying 45.
BMO BCH NTB BMO BGSF FUN
Investors in Hertz Global Holdings, Inc. (HTZ - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 17, 2018 $11.00 Put had some of the highest implied volatility of all equity options today.
EFR UUUU BGSF FUN HRI HTZ
Post Holdings, Inc. (POST - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $85.17 to $88.94 in the past one month time frame.
POST POSTZ POSTU POSHZ EFR PF UUUU BGSF FUN
Cardinal Health Inc. (CAH - Free Report) reported fourth-quarter fiscal 2018 adjusted earnings of $1.01 per share, beating the Zacks Consensus Estimate of 93 cents. Adjusted earnings declined 22.9% year over year.
CAH ISRG CHE ILMN BGSF FUN
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to FUN / Cedar Fair, L.P. on message board site Silicon Investor.
as of ET